COVRelief (NRICM101) by Chuang Song Zong Pharmaceutical Co., LTD.

  • COVRelief (NRICM101) by Chuang Song Zong Pharmaceutical Co., LTD. 1
  • COVRelief (NRICM101) by Chuang Song Zong Pharmaceutical Co., LTD. 2
  • COVRelief (NRICM101) by Chuang Song Zong Pharmaceutical Co., LTD. 3
Product Description

“COVRelief ” EUIPO Trade mark No. 018316519COVRelief (NRICM101) is a prescription traditional Chinese medicine (TCM)developed by the National Research Institute of Chinese Medicine (NRICM) MOHWin 2020 for the symptom relief of mild to moderate COVID-19 infection. Thecomponents of NRICM101 were designed based on a medicinal formula with a longhistory from almost 500 years ago for treatments of wind-cold-dampness or flu andadjusted to better treat the conditions of patients with COVID-19 infection. In 2024,CSZ implemented a two-year Phase III Clinical Trial to conduct a multicenter,randomized, double-blind, controlled test. Evaluate the Efficacy of COVRelief(NRICM101) in the Treatment of Externally Contracted Seasonal EpidemicsIn 2021-2022 Obtained approval listing in Singapore and Thailand.

Read more Show less

Taiwan Institute of Economic Research

  • Country/Region:
    Taiwan
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
Academic/Research
Association/Government
Contract Service
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Natural Extracts
Nutraceuticals
View company profile
Categories
more categories Show less
Specifications
  • Details
    Indications：Externally contracted seasonal epidemic.
  • Selling Points
    Immune Health
  • Model
    Concentrated granules
  • Supplied from
    Taiwan
More specifications Fewer specifications
Sales Markets
Show more Show less

Taiwan Institute of Economic Research

  • Country/Region:
    Taiwan
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
Academic/Research
Association/Government
Contract Service
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Natural Extracts
Nutraceuticals
View company profile

More Products from Taiwan Institute of Economic Research (2)

  • Taiwan NRICM201 by Li Kang Biotechnical Co., Ltd.

    Product Taiwan NRICM201 by Li Kang Biotechnical Co., Ltd.

    Developed by integrating Traditional Chinese Medicine and modern neuroscience, NRICM201 is a multi-herbal formulation specifically designed to support cognitive health in older adults and individuals with mild cognitive concerns. The formula includes documented herbal extracts such as Gastrodia...
  • COFUL REMEDY Taiwan Chingguan No.1(NRICM101) by Li Kang Biotechnical

    Product COFUL REMEDY Taiwan Chingguan No.1(NRICM101) by Li Kang Biotechnical

    NRICM101 was developed by Taiwan's National Research Institute of Chinese Medicine in 2020 as a treatment for mild to moderate COVID-19. It combines traditional Chinese medicinal theory with modern clinical practice. This concentrated herbal granule formulation contains 10 herbs, produced under GMP-certifi...

Taiwan Institute of Economic Research resources (2)

  • Taiwan Showcases Evidence-Based TCM at CPHI Frankfurt 2025

    News Taiwan Showcases Evidence-Based TCM at CPHI Frankfurt 2025

    Taiwan's healthcare system, ranked No. 1 worldwide in CEOWORLD Magazine's 2024 Health Care Index, is built on the integration of modern medicine with proven Traditional Chinese Medicine (TCM). At CPHI Frankfurt 2025, organized by Taiwan Institute of Economic Research, the Taiwan Traditional Chinese Medicine Pavilion (stand 12.1 C112) will highlight how Taiwan combines scientific validation with centuries of herbal wisdom to create innovative solutions for global health.
    22 Oct 2025
  • Taiwan Traditional Chinese Medicine Pavilion

    Brochure Taiwan Traditional Chinese Medicine Pavilion

    At CPHI Frankfurt 2025, Taiwan’s National Pavilion will showcase five leading companies — Chuang Song Zong, Li Kang Biotech, Timing Pharmaceutical, Taiwan Three Mast, and Grape King Bio — exemplifying how scientific validation drives commercial innovation in Traditional Chinese Medicine.